Daisy Mugo - KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 42 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Low-Dose Yellow Fever Vaccine in Adults in Africa

Derick Kimathi,Aitana Juan-Giner,Ndeye S Bob,Benedict Orindi, Maria L Namulwana, Antoine Diatta,Stanley Cheruiyot,Gamou Fall,Moussa Dia,Mainga M Hamaluba,Dan Nyehangane,Henry K Karanja,John N Gitonga,Daisy Mugo,Donwilliams O Omuoyo, Mwatasa Hussein, Elizaphan Oloo, Naomi Kamau, Jackline Wafula, Josephine Bendera, Namanya Silvester, James Mwavita, Musiimenta Joshua, Jane Mwendwa, Collins Agababyona,Caroline Ngetsa,Nalusaji Aisha, Felix Moki, Titus Buluku,Marianne Munene,Juliet Mwanga-Amumpaire,Julius Lutwama,John Kayiwa,Eunice Kamaara,Alan D Barrett,Pontiano Kaleebu,Philip Bejon,Amadou A Sall,Rebecca F Grais,George M Warimwe, NIFTY Investigators

The New England journal of medicineno. 8 (2025): 788-797

Cited0Views0WOSBibtex

Kinetics of Naturally Induced Binding and Neutralising Anti-Sars-cov-2 Antibody Levels and Potencies among SARS-CoV-2 Infected Kenyans with Diverse Grades of COVID-19 Severity: an Observational Study

John Kimotho,Yiakon Sein,Shahin Sayed,Reena Shah,Kennedy Mwai,Mansoor Saleh,Perpetual Wanjiku,Jedidah Mwacharo,James Nyagwange,Henry Karanja,Bernadette Kutima,John N Gitonga,Daisy Mugo, Ann Karanu, Linda Moranga, Viviane Oluoch,Jasmit Shah,Julius Mutiso, Alfred Mburu,Zaitun Nneka, Peter Betti,Wanzila Usyu Mutinda,Abdirahman Issak Abdi,Philip Bejon,Lynette Isabella Ochola-Oyier,George M Warimwe,Eunice W Nduati,Francis M Ndungu

Wellcome open research (2024): 350-350

Cited0Views0WOSBibtex

Kinetics of Naturally Induced Binding and Neutralising Anti-Sars-cov-2 Antibody Levels and Potencies among SARS-CoV-2 Infected Kenyans with Diverse Grades of COVID-19 Severity: an Observational Study [version 2; Peer Review: 2 Approved]

Mansoor Saleh,Reena Shah, Linda Moranga, Ann Karanu,Jasmit Shah, Viviane Oluoch,Henry Karanja, Alfred Mburu,Julius Mutiso, Peter Betti,Daisy Mugo,Zaitun Nneka,Abdirahman Issak Abdi,Wanzila Usyu Mutinda,George M.Warimwe,Lynette Isabella Ochola-Oyier,James Nyagwange,Yiakon Sein,Francis M. Ndungu,Bernadette Kutima,John N. Gitonga,Philip Bejon,Perpetual Wanjiku,Eunice W. Nduati,Jedidah Mwacharo,Kennedy Mwai,Shahin Sayed, John Kimotho

Wellcome Open Research (2024)

Cited0Views0Bibtex

Evaluation of Population Immunity Against SARS-CoV-2 Variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 Using Samples from Two Health Demographic Surveillance Systems in Kenya

Doreen Lugano,Bernadette Kutima,Makobu Kimani,Antipa Sigilai,John Gitonga,Angela Karani,Donald Akech,Boniface Karia,Abdhalah K. Ziraba, Angela Maina,Arnold Lambisia,Donwilliams Omuoyo,Daisy Mugo,Ruth Lucinde, Sharon Owuor, Gloria Konyino,Joseph Newman,Dalan Bailey,Eunice Nduati,George Githinji,Charles N. Agoti,Philip Bejon,J. Anthony G. Scott,Ambrose Agweyu, Wangeci Kagucia,George M. Warimwe,Charles Sande,Lynette I. Ochola-Oyier,James Nyagwange

BMC Infectious Diseasesno. 1 (2024): 1-10

Cited0Views0WOSBibtex

Safety and Immunogenicity of a ChAdOx1 Vaccine Against Rift Valley Fever in UK Adults: an Open-Label, Non-Randomised, First-in-human Phase 1 Clinical Trial

Daniel Jenkin,Daniel Wright,Pedro M. Folegatti,Abigail Platt,Ian Poulton,Alison Lawrie, Nguyen Tran,Amy Boyd,Cheryl Turner,John N. Gitonga,Henry K. Karanja,Daisy Mugo,Katie J. Ewer,Thomas A. Bowden,Sarah C. Gilbert,Bryan Charleston,Pontiano Kaleebu,Adrian V. S. Hill,George M. Warimwe

The Lancet Infectious Diseasesno. 8 (2023): 956-964

Cited9Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn